Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
P/E ratio for Fagron NV (FAGR.BR)
P/E ratio as of 2023: 17.19
According to Fagron NV's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.19. At the end of 2022 the company had a P/E ratio of 13.89.
P/E ratio history for Fagron NV from 2004 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 17.19 |
| 2022 | 13.89 |
| 2021 | 17.62 |
| 2020 | 22.98 |
| 2019 | 24.92 |
| 2018 | 24.11 |
| 2017 | 17.76 |
| 2016 | -25.48 |
| 2015 | -1.09 |
| 2014 | 66.06 |
| 2013 | -26.48 |
| 2012 | 11.09 |
| 2011 | 11.83 |
| 2010 | 15.16 |
| 2009 | 12.43 |
| 2008 | 12.92 |
| 2007 | 15.16 |
| 2006 | 20.59 |
| 2005 | 16.57 |
| 2004 | 18.09 |